Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $19,172 | 1 | 70.0% |
| Unspecified | $7,500 | 1 | 27.4% |
| Food and Beverage | $687.16 | 19 | 2.5% |
| Education | $14.13 | 1 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $19,172 | 1 | $0 (2021) |
| OPHTEC USA, Inc. | $7,500 | 1 | $0 (2023) |
| Oyster Point Pharma, Inc. | $275.62 | 3 | $0 (2023) |
| Allergan Inc. | $150.22 | 3 | $0 (2018) |
| Shire North American Group Inc | $135.72 | 9 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $73.34 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $39.47 | 2 | $0 (2021) |
| Mallinckrodt LLC | $14.13 | 1 | $0 (2017) |
| Sun Pharmaceutical Industries Inc. | $12.79 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $7,572 | 3 | OPHTEC USA, Inc. ($7,500) |
| 2022 | $203.65 | 1 | Oyster Point Pharma, Inc. ($203.65) |
| 2021 | $19,193 | 2 | PFIZER INC. ($19,172) |
| 2020 | $73.34 | 1 | Mallinckrodt Hospital Products Inc. ($73.34) |
| 2019 | $31.90 | 2 | Shire North American Group Inc ($19.11) |
| 2018 | $13.48 | 1 | Allergan Inc. ($13.48) |
| 2017 | $286.09 | 12 | Allergan Inc. ($136.74) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2023 | OPHTEC USA, Inc. | — | — | Cash or cash equivalent | $7,500.00 | Research |
| Study: Artisan Aphakia Lens for the Correction of Aphakia in Adults | ||||||
| 11/04/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $36.97 | General |
| Category: DRY EYE | ||||||
| 11/04/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: DRY EYE | ||||||
| 05/18/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $203.65 | General |
| Category: DRY EYE | ||||||
| 12/21/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $19,172.00 | General |
| 12/03/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/11/2020 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $73.34 | General |
| Category: IMMUNOLOGY | ||||||
| 03/05/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: OPTHALMICS | ||||||
| 02/13/2019 | Sun Pharmaceutical Industries Inc. | XELPROS (Drug) | Food and Beverage | Cash or cash equivalent | $12.79 | General |
| Category: Ophthalmology | ||||||
| 11/08/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2017 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/31/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: OPTHALMICS | ||||||
| 08/24/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: OPTHALMICS | ||||||
| 07/27/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: OPTHALMICS | ||||||
| 06/01/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: OPTHALMICS | ||||||
| 05/31/2017 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $120.24 | General |
| 05/25/2017 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: DRY EYE | ||||||
| 05/04/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: OPTHALMICS | ||||||
| 04/13/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: OPTHALMICS | ||||||
| 03/31/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Education | In-kind items and services | $14.13 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 03/23/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: OPTHALMICS | ||||||
| 01/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: OPTHALMICS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Artisan Aphakia Lens for the Correction of Aphakia in Adults | OPHTEC USA, Inc. | $7,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 32 | 32 | $6,880 | $2,667 |
| 2021 | 1 | 22 | 22 | $4,400 | $1,960 |
| 2020 | 1 | 35 | 37 | $7,400 | $3,170 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2022 | 20 | 20 | $4,000 | $1,548 | 38.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 12 | 12 | $2,880 | $1,120 | 38.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 22 | 22 | $4,400 | $1,960 | 44.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 35 | 37 | $7,400 | $3,170 | 42.8% |
About Dr. Jonathan Lass, MD
Dr. Jonathan Lass, MD is a Ophthalmology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1366431942.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Lass, MD has received a total of $27,373 in payments from pharmaceutical and medical device companies, with $7,572 received in 2023. These payments were reported across 22 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($19,172).
As a Medicare-enrolled provider, Lass has provided services to 89 Medicare beneficiaries, totaling 91 services with total Medicare billing of $7,797. Data is available for 3 years (2020–2022), covering 4 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Cleveland, OH
- Active Since 10/17/2005
- Last Updated 01/10/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1366431942
Products in Payments
- TYRVAYA (Drug) $275.62
- XIIDRA (Drug) $156.58
- ACTHAR (Biological) $87.47
- DUREZOL (Drug) $18.61
- RESTASIS (Drug) $16.50
- COMBIGAN (Drug) $13.48
- XELPROS (Drug) $12.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Cleveland
Peter Kaiser, Md, MD
Ophthalmology — Payments: $1.7M
Dr. Justis Ehlers, M.d, M.D
Ophthalmology — Payments: $818,485
William Wiley, M.d, M.D
Ophthalmology — Payments: $775,102
Sunil Srivastava, Md, MD
Ophthalmology — Payments: $668,061
Yasha Modi, M.d, M.D
Ophthalmology — Payments: $244,095
Dr. Douglas Rhee, M.d, M.D
Ophthalmology — Payments: $162,043